
technologyAug 15, 202344:31pending
Ep. 139: Biomarkers and personalized medicine | Mohit Jain
About this episode
Dr. Mohit Jain is a physician-scientist with more than 20 years of expertise in physiology, biomedicine, engineering, computational biology, and mass spectrometry-based metabolomics. Prior to founding Sapient, he formed and was director of Jain Laboratory at the University of California San Diego (UCSD). There he led a multi-disciplinary research team to develop next-generation systems to probe the non-genetic landscape of disease, supported by over $30M in federal, foundation, and industry funding. Dr. Jain founded Sapient in 2021 as a spinout of Jain Laboratory to expand upon the mission of accelerating human discovery and drug development through the nexus of high throughput analytical mass spectrometry, computational biology, and population-level biomarker profiling.
If you enjoy this interview please subscribe to the podcast and share it with your friends, and don't forget to check out our website, futuratipodcast.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time FUTURATI PODCAST publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from FUTURATI PODCAST

Episode 172: Capitalism Evolving—or Collapsing | Any Hines
FUTURATI PODCAST
Mar 6, 202552:43pending

Ep. 171: China, Communism, and Bitcoin | Roger Huang
FUTURATI PODCAST
Nov 5, 20241:13:54pending

Ep. 170: The story of the first AGI | David Jilk
FUTURATI PODCAST
Oct 22, 202445:03pending

Ep. 169: Fractal University, Scenius, and the future of higher ed. | Andrew Rose
FUTURATI PODCAST
Oct 8, 20241:07:12pending